Kommentar zu „Leitlinie zur Behandlung der Kopf-Hals-Karzinome – ein kritischer Blick“

• Literatur

• 1 Ho SY, Tsang RKY. Value of oesophagoscopy and bronchoscopy in diagnosis of synchronous malignancies in patients with head and neck squamous cell carcinomas. BMC Cancer 2020; 20
• 2 Nauta IH, Rietbergen MM, van Bokhoven AAJD. et al. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing. Ann Oncol 2018; 29: 1273-1279
• 3 Massey C, Dharmarajan A, Bannuru RR. et al. Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis. Laryngoscope 2019; 129: E284-E298
• 4 van Lanschot CGF, Klazen YP, de Ridder MAJ. et al. Depth of invasion in early stage oral cavity squamous cell carcinoma: The optimal cut-off value for elective neck dissection. Oral Oncol 2020; 111: 104940
• 5 D’Cruz AK, Vaish R, Kapre N. et al. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. N Engl J Med 2015; 373: 521-529
• 6 Hoffmann TK. ORATOR study: Surgery or radiotherapy for oropharyngeal carcinoma in the context of HPV?. HNO 2020; 68: 278-279
• 7 Chang JH, Wu CC, Yuan KSP. et al. Locoregionally recurrent head and neck squamous cell carcinoma: Incidence, survival, prognostic factors, and treatment outcomes. Oncotarget 2017; 8: 55600-55612
• 8 Lupato V, Polesel J, La Torre FB. et al. A pre-operative prognostic score for the selection of patients for salvage surgery after recurrent head and neck squamous cell carcinomas. Sci Rep 2021; 11: 502